Skin biopsy as a diagnostic tool in dystrophinopathies has been already reported, as dystrophin is expressed at the plasma membrane of arrector pili smooth muscle cells (Tanveer et al., 2009; Ferlini et al., 2010). This evidence concerns the gene DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin.